Galloway-Mowat syndrome 1 is a rare genetic condition that affects the brain and kidneys. Early signs often include small head size and developmental delay, and some babies have feeding problems or seizures. Kidney disease can develop in infancy or early childhood and may progress to kidney failure. Care focuses on supportive therapies, seizure control, nutrition, and kidney care, and some children may need dialysis or a transplant. The condition can be severe and life-limiting in many cases, but care teams work to improve comfort and quality of life.
Overview
Galloway-mowat syndrome 1Symptoms
Galloway-mowat syndrome 1 features begin in early infancy: small head size, weak muscle tone, feeding trouble, seizures, and severe developmental delays. Many also develop serious kidney disease with swelling and heavy protein loss, leading to poor growth and fatigue.
Outlook and prognosis
Many living with Galloway‑Mowat syndrome 1 face serious, early‑onset challenges affecting the brain, kidneys, and growth. Symptoms often progress over childhood, and kidney disease can be life‑limiting. Supportive care, seizure control, nutrition, and kidney management may extend comfort and time.
Causes and risk factors
Galloway-Mowat syndrome 1 stems from harmful WDR73 gene changes, typically inherited in an autosomal recessive way. Risk rises when both parents are carriers, especially when parents are related by blood. No proven lifestyle or environmental triggers are known.
Genetic influences
Genetics is central in Galloway-Mowat syndrome 1, which is caused by inherited changes in specific genes, most often WDR73. It follows an autosomal recessive pattern, so both parents typically carry one nonworking copy. Genetic testing confirms the diagnosis and guides family planning.
Diagnosis
Doctors suspect it from clinical features—small head size, developmental delays, and heavy protein loss in urine—plus blood and urine tests and brain MRI. Genetic diagnosis of Galloway-mowat syndrome 1 is confirmed with gene testing; kidney biopsy may support the diagnosis.
Treatment and drugs
Treatment for Galloway-Mowat syndrome 1 focuses on comfort, growth, and protecting kidney and brain function. Care often includes seizure control, nutrition support, physiotherapy, and timely management of kidney disease, sometimes with dialysis or transplant. A coordinated team tailors plans as needs change.
Symptoms
Galloway-mowat syndrome 1 affects early brain development and the kidneys, so many families notice delays and swelling in infancy or early childhood. The early features of Galloway-mowat syndrome 1 can include a smaller head size, weak muscle tone, feeding challenges, and puffiness from kidney problems. Features vary from person to person and can change over time. Doctors often confirm specific differences with exams and imaging, but the day-to-day effects are usually what bring families in for assessment.
In medical terms, this is microcephaly; in everyday life, it shows up as a head size that measures smaller than expected. Pediatricians track this with regular head measurements. It does not cause pain, but it is a clue to brain development differences.
Many children with Galloway-mowat syndrome 1 reach milestones like rolling, sitting, walking, and talking later than peers. Therapy can support motor, speech, and daily skills. Progress often comes, just at a different pace.
Babies may feel floppy, have poor head control, and tire easily during play or feeding. Some later develop stiff muscles or tightness in the limbs. Physical therapy and supportive equipment can make positioning and movement safer.
Some children with Galloway-mowat syndrome 1 have episodes of staring, twitching, or whole-body shaking. These events can be brief or longer and often need urgent medical review. Seizure medicines and care plans can reduce how often they happen.
How people usually first notice Galloway-mowat syndrome 1?
Parents and doctors often first notice Galloway-Mowat syndrome 1 in early infancy when a baby’s head size is smaller than expected (microcephaly) and the baby may have low muscle tone, feeding difficulties, or seizures. As weeks to months go by, delays in reaching milestones and unusual eye or movement patterns can raise concern, leading to brain imaging and genetic testing that clarify the diagnosis. Some families first encounter the condition through kidney problems such as protein in the urine or swelling, so the first signs of Galloway-Mowat syndrome 1 may be either early neurologic changes or early kidney findings, depending on the child.
Types of Galloway-mowat syndrome 1
Galloway-Mowat syndrome 1 is a rare genetic condition with a few recognized clinical variants, mainly defined by the gene change and the age symptoms begin. Differences often show up in early brain development, muscle tone, seizures, and how quickly kidney problems progress. People may notice different sets of symptoms depending on their situation. When you look at types of Galloway-Mowat syndrome 1, earlier-onset forms tend to be more severe, while later-onset forms may progress more gradually.
Classic early-onset
Symptoms begin in the first months of life with low muscle tone, developmental delay, and small head size. Seizures are common early, and kidney disease often progresses quickly to significant protein loss. This variant typically leads to earlier complications.
Infantile-onset milder
Signs appear later in infancy with developmental delays that may be less pronounced at first. Seizures may occur but can be less frequent, and kidney issues progress more slowly. Some children maintain skills longer before decline.
Childhood-onset renal-predominant
Neurologic features are milder initially, and school-age onset of kidney problems stands out. Protein in the urine and swelling may be the first clear signs, with slower neurologic changes over time. Monitoring focuses on kidney health while tracking learning and motor skills.
Severe neonatal variant
Symptoms start at or right after birth with profound low muscle tone, feeding difficulties, and early seizures. Brain development differences are marked, and kidney failure can develop rapidly. Care needs are intensive from the outset.
What genetics can tell you about symptoms
Changes in the WDR73 gene disrupt how brain and kidney cells develop and survive, leading to early-onset seizures, profound developmental delay, small head size, and muscle stiffness. Many also develop kidney problems like protein loss and nephrotic syndrome, often progressing to kidney failure.
Causes and risk factors
Galloway-Mowat syndrome 1 is usually caused by harmful changes in the WDR73 gene. Some risks are written in our DNA, passed down through families. It is most often inherited in an autosomal recessive pattern, so a child is affected when both parents carry the change. Key risk factors for Galloway-Mowat syndrome 1 include having carrier parents and parents who are related by blood. Lifestyle does not cause the condition, but infections, dehydration, and some medicines that stress the kidneys can worsen outcomes.
Environmental and biological risk factors
Many families want clear answers about why Galloway-Mowat syndrome 1 (GAMOS1) happens and whether anything in the body or environment raises the chance. Doctors often group risks into internal (biological) and external (environmental). With this rare condition, current research points to causes that arise very early in development, and confirmed outside triggers are limited. Below is what is—and isn’t—known about environmental and biological risk factors for Galloway-Mowat syndrome 1.
There are currently no proven environmental exposures that increase the likelihood of Galloway-Mowat syndrome 1. Studies have not identified toxins, infections, or pollutants that consistently raise risk.
Advanced maternal or paternal age has not been shown to increase risk of GAMOS1. Patterns tied to age-related chromosomal changes do not fit this condition.
Common pregnancy conditions such as diabetes or high blood pressure are not known to cause Galloway-Mowat syndrome 1. Prenatal care remains important for overall pregnancy health.
Labor or delivery complications do not create GAMOS1. Features linked to the condition begin early in fetal development.
Genetic risk factors
Galloway-Mowat syndrome 1 is driven by changes in a single gene that are inherited from both parents. Some risk factors are inherited through our genes. Here’s what we know about the genetic causes of Galloway-Mowat syndrome 1. Understanding these patterns can help families make sense of recurrence risk within the family.
WDR73 gene changes: Two harmful changes in the WDR73 gene lead to this condition. The gene helps brain and kidney cells develop and stay healthy. A confirmed WDR73 change distinguishes type 1 from other subtypes.
Autosomal recessive pattern: Galloway-Mowat syndrome 1 occurs when both copies of WDR73 have harmful changes (autosomal recessive). Parents typically carry one change each and have no symptoms. This pattern explains why more than one child in a family can be affected.
Carrier risk per pregnancy: If both parents are WDR73 carriers, each pregnancy has a 25% (1 in 4) chance of being affected. There is also a 50% (1 in 2) chance the child will be a healthy carrier. The remaining 25% chance is for a child with two working copies of the gene.
Consanguinity: When parents are related by blood, they are more likely to carry the same rare change. This increases the chance a child inherits two WDR73 changes. Genetic counseling can help families understand this risk.
Variant differences: Not all WDR73 changes affect the gene in the same way. Some variants are linked with earlier or more severe kidney problems, while others may lead to slower changes. This can influence outlook but not the basic inheritance pattern.
Family history: Having a sibling with confirmed WDR73-related Galloway-Mowat syndrome 1 strongly suggests both parents are carriers. Targeted testing can identify who else in the family carries the change. This helps clarify who faces inherited risk and who does not.
Lifestyle risk factors
Galloway-mowat syndrome 1 is a genetic condition; lifestyle habits do not cause it, but daily routines can influence symptoms, complications, and quality of life. Understanding how lifestyle affects Galloway-mowat syndrome 1 helps families support growth, kidney health, and neurologic comfort. The elements below focus on practical, condition-specific habits rather than causes or cures.
Lower-sodium foods can reduce edema and make breathing and mobility easier. Balanced protein supports growth without adding undue kidney strain. Monitoring potassium and phosphorus as advised helps prevent dangerous buildups.
Upright positioning and slow, appropriately thickened feeds can lower aspiration and pneumonia risk. Small, frequent meals may ease reflux and improve tolerance. Careful oral hygiene after feeds reduces aspiration from residuals.
Fluid amounts tailored to current kidney status help prevent fluid overload or dehydration. Tracking daily intake and urine output supports timely adjustments. Extra caution during illness can avert acute kidney stress.
Gentle daily range-of-motion and supported standing help maintain joint mobility and bone health. Regular, low-intensity activity can improve muscle tone and breathing efficiency. Consistency matters more than intensity.
Risk prevention
Galloway-Mowat syndrome 1 is a genetic condition, so we can’t prevent it from developing, but we can lower the chance of complications and support long-term health. Prevention is about lowering risk, not eliminating it completely. Spotting early symptoms of Galloway-Mowat syndrome 1 and closely checking kidney health can make a meaningful difference. Care plans work best when families and clinicians partner regularly and adjust steps as needs change.
Learn how the condition is inherited and your chances in future pregnancies. Discuss options like carrier testing, prenatal testing, or IVF with embryo testing.
Regular urine checks for protein, blood tests, and blood pressure tracking can pick up kidney strain early. Early treatment of protein loss and swelling may slow complications in Galloway-Mowat syndrome 1.
Staying up to date on routine vaccines reduces serious infections. Handwashing and avoiding sick contacts during outbreaks add another layer of protection.
Fevers, breathing issues, or urinary symptoms should be evaluated quickly. Fast treatment can limit kidney stress and prevent dehydration in Galloway-Mowat syndrome 1.
Transmission
Galloway-Mowat syndrome 1 is not contagious—you can’t catch it or pass it through casual contact. It is a genetic condition passed from parents to children in an autosomal recessive pattern: most often, both parents carry one non-working copy of the same gene and do not have symptoms. When two carriers have a child, there is a 25% (1 in 4) chance the child will have Galloway-Mowat syndrome 1, a 50% (1 in 2) chance the child will be a carrier like the parents, and a 25% chance the child will inherit neither non-working copy. While rare, genetic transmission of Galloway-Mowat syndrome 1 can also appear in families with no known history because carrier status often goes unnoticed.
When to test your genes
Consider genetic testing if a child shows early kidney disease with neurologic features (such as developmental delay or seizures), especially with microcephaly or structural brain differences. Testing is also reasonable when there’s a family history of Galloway‑Mowat syndrome or unexplained infant kidney failure. Results can guide care, surveillance, and family planning.
Diagnosis
When Galloway-Mowat syndrome 1 is suspected, doctors look at a mix of early kidney problems and neurologic signs, often starting in infancy. Getting a diagnosis is often a turning point toward answers and support. The genetic diagnosis of Galloway-Mowat syndrome 1 is usually confirmed with a DNA test after initial exams and imaging point in this direction. Because features can vary, several steps come together to provide a clear picture.
Doctors review early symptoms such as swelling, heavy urine protein loss, small head size, and developmental delays. These patterns help raise suspicion for Galloway-Mowat syndrome 1.
A detailed family and health history can help connect early kidney and neurologic issues to an inherited cause. Knowing whether relatives had similar problems or early kidney disease can guide testing.
Head circumference and overall growth are measured and tracked over time. Marked microcephaly (a smaller head size) supports the clinical picture of Galloway-Mowat syndrome 1.
Doctors assess muscle tone, reflexes, vision, hearing, and seizure history. Findings such as low muscle tone or seizures help support the diagnosis.
Stages of Galloway-mowat syndrome 1
Galloway-mowat syndrome 1 does not have defined progression stages. It affects multiple systems in different ways, so changes over time depend on the person’s kidney health and neurological development rather than moving through set steps; early symptoms of Galloway-mowat syndrome 1 may include small head size, feeding difficulties, low muscle tone, or seizures. Doctors assess current features and impact with a physical exam, growth measurements, urine and blood tests to check kidney function, and brain studies when needed, and genetic testing may be offered to clarify certain risks. Ongoing care usually involves regular monitoring of urine protein, blood pressure, and development to track changes and guide treatment.
Outlook and prognosis
Looking at the long-term picture can be helpful. Galloway-Mowat syndrome 1 is a rare, serious condition that affects brain development and the kidneys, so day-to-day life often involves frequent appointments, feeding support, and careful infection prevention. Many people ask, “What does this mean for my future?”, and the honest answer is that outcomes vary with how early and how severely the kidneys and nervous system are involved.
Prognosis refers to how a condition tends to change or stabilize over time. In many children with Galloway-Mowat syndrome 1, early symptoms include feeding trouble, slow growth, seizures, and developmental delays during infancy; kidney disease may appear early or later, and it often progresses. When kidney scarring advances to kidney failure, survival depends on access to dialysis and, in some cases, transplant—both can add years, but they also bring significant medical needs. Severe neurological involvement can limit mobility, speech, and swallowing, and it raises the risk of infections and breathing complications. Mortality is unfortunately high in early childhood for those with both profound neurological symptoms and rapidly worsening kidney disease, though some children with milder kidney involvement live longer into later childhood or adolescence.
Everyone’s journey looks a little different. Early care can make a real difference, especially when seizures are controlled, nutrition is supported, and kidney issues are monitored closely so treatment starts promptly. Families often want to know what role they can play, and staying on top of vaccines, managing reflux and constipation, using feeding supports when needed, and having a plan for seizures can reduce urgent hospital visits. Talk with your doctor about what your personal outlook might look like, including whether genetic results, current kidney function, and growth patterns can help refine expectations over time.
Long-term effects
People with Galloway-Mowat syndrome 1 tend to face long-term effects that involve the kidneys and the developing brain. Over time, daily routines may adapt around frequent monitoring and supportive care. Many families first notice early symptoms of Galloway-Mowat syndrome 1 in infancy, but long-term outcomes are usually shaped by kidney function and neurologic features. The course can be severe for some, while others have a slower progression; survival depends largely on how quickly kidney failure and brain-related complications advance.
Ongoing protein loss in the urine and swelling can lead to gradual loss of kidney function. Many develop kidney failure in early childhood, sometimes requiring dialysis or a transplant.
Lasting delays in motor skills, speech, and learning are common. Many need long-term support for mobility, communication, and daily activities.
Recurrent seizures may start in infancy and can persist. Frequency and severity vary over time, and some remain difficult to control.
Low or mixed muscle tone affects posture, coordination, and stability. This can lead to joint stiffness, contractures, or scoliosis as children grow.
How is it to live with Galloway-mowat syndrome 1?
Living with Galloway-Mowat syndrome 1 often means navigating complex medical care from infancy, with seizures, feeding challenges, and significant developmental delays shaping daily routines. Families typically coordinate therapies, manage kidney monitoring and medications, and adapt the home for comfort and safety, celebrating small gains while planning around frequent appointments. For many, the condition influences siblings and caregivers too, who may balance worry and fatigue with strong advocacy and a close partnership with medical teams. Despite the demands, thoughtful support, respite services, and clear care plans can ease day-to-day life and help everyone involved feel more secure.
Treatment and drugs
Treatment for Galloway-Mowat syndrome 1 focuses on easing symptoms, protecting kidney function, and supporting development, since there’s no cure yet. Supportive care can make a real difference in how you feel day to day. Care teams often include kidney specialists, neurologists, dietitians, therapists, and genetic counselors; management may involve anti-seizure medicines for epilepsy, nutritional support for feeding difficulties, physical and occupational therapy, and prompt treatment of infections. For kidney disease, doctors monitor blood pressure and urine protein, adjust diet and fluids, and may use medicines that reduce protein loss; in advanced stages, dialysis or kidney transplant can be considered, while seizure control and overall health guide timing. Because needs can change over time, treatment plans are reviewed regularly to adjust medicines, doses, and therapies as the child grows.
Non-drug treatment
Daily life with Galloway-Mowat syndrome 1 often revolves around feeding, movement, learning, and kidney care. Beyond prescriptions, supportive therapies can help children stay safer, grow as well as possible, and participate in family life. Because early symptoms of Galloway-Mowat syndrome 1 often involve feeding and development, starting non-drug care early can make day-to-day routines smoother. Plans are tailored to each child and usually combine several approaches over time.
A kidney-friendly eating plan focuses on the right balance of protein, salt, and fluids. A renal dietitian can tailor meals to growth needs and lab results. Families get practical tips for shopping, cooking, and hydration.
When kidneys struggle, peritoneal or hemodialysis can remove wastes and extra fluid. Teams teach catheter care, infection prevention, and how to fit treatments into home routines. Planning ahead helps avoid urgent procedures.
High-calorie, nutrient-dense meals support growth when eating is slow or tiring. Fortified feeds or tube feeding can bridge gaps when weight gain stalls. Regular monitoring helps adjust the plan as needs change.
A speech-language therapist assesses swallowing safety and reduces choking risk. Texture changes and positioning can make mealtimes safer and less stressful. Caregivers learn techniques they can use at home.
Your genes may have an impact on how drugs work for you
Medicines for Galloway-Mowat syndrome 1 can act differently because gene changes may alter how the body processes drugs and how kidneys and brain cells respond. Genetic testing and careful dosing help clinicians choose safer options and avoid side effects.
Pharmacological treatments
Day-to-day care in Galloway-Mowat syndrome 1 focuses on easing swelling, protecting kidney function, and treating neurologic symptoms that may affect comfort and development. Even when early symptoms of Galloway-Mowat syndrome 1 begin in infancy, medicines can reduce protein loss in the urine and help control fluid buildup. Not everyone responds to the same medication in the same way. Your team will adjust choices over time, based on kidney status, growth, and how your child feels.
Enalapril or lisinopril can reduce protein leak from the kidneys and lower blood pressure. This may slow kidney strain and swelling.
Losartan or valsartan offer a similar effect if ACE inhibitors aren’t tolerated. They can lower protein in the urine and protect kidney function.
Furosemide and sometimes spironolactone help the body release extra fluid. This can ease puffiness around the eyes and ankles and improve breathing comfort.
Human albumin given through a vein can temporarily pull fluid back into the bloodstream. A dose of furosemide often follows to remove the excess fluid safely.
Genetic influences
Galloway-Mowat syndrome 1 arises from inherited changes in a gene that helps the brain and kidneys develop and function. It follows an autosomal recessive pattern: a child is affected only when both parents silently carry the same gene change and each passes it on. In that situation, each pregnancy has a 25% chance of a child with the condition, a 50% chance of a carrier without symptoms, and a 25% chance of a child without the change. Different families may have different changes within this gene, and even relatives who share the same change can be affected to different degrees. Genetic testing can often pinpoint the underlying change and confirm the diagnosis, helping doctors explain the genetic causes of Galloway-Mowat syndrome 1 and rule out look-alike conditions. To put these pieces together, doctors may suggest genetic counseling. Results can also clarify the chance of early symptoms of Galloway-Mowat syndrome 1 appearing in future children and inform family planning.
Is Galloway-mowat syndrome 1 genetic?
Genetics is central in Galloway-Mowat syndrome 1, which is caused by inherited changes in specific genes, most often WDR73. It follows an autosomal recessive pattern, so both parents typically carry one nonworking copy. Genetic testing confirms the diagnosis and guides family planning.
Pharmacogenetics—how genetics influence drug effects
Because Galloway-Mowat syndrome 1 stems from changes in genes that affect the kidneys and brain, treatment decisions often lean toward supportive care and careful medicine choices. When kidney function is reduced, the body clears many drugs more slowly, so doses of antibiotics, seizure medicines, and pain relievers often need adjustment to avoid buildup and side effects. A genetic diagnosis of Galloway-Mowat syndrome 1 can also spare children from repeated courses of steroids or other immune-suppressing drugs that typically help some kinds of nephrotic syndrome but are less likely to work here. Alongside medical history and kidney function, genetic testing can help tailor medicine choices and doses. Because protein levels in the blood may be low with heavy urine protein loss, some drugs that usually attach to blood proteins can have stronger effects than expected, so doctors often start low and monitor closely. Overall, genetics shapes the care plan for Galloway-Mowat syndrome 1 by signaling which therapies are worth trying and how to dose everyday medicines more safely.
Interactions with other conditions
Living with Galloway-Mowat syndrome 1 often means managing kidney problems and neurologic needs at the same time, so a cold, stomach bug, or even mild dehydration can hit harder—swelling may worsen, seizures can be more likely, and energy dips are common. Infections can “tip” the kidneys into losing more protein, and medicines used for fevers or pain (like some anti-inflammatories) may strain already vulnerable kidneys, so care teams usually steer people toward kidney-safe options. Doctors call it a “comorbidity” when two conditions occur together, and in Galloway-Mowat syndrome 1, epilepsy, feeding difficulties, reflux, and high blood pressure are frequent partners that can complicate day-to-day care. Blood clots and low albumin linked to nephrotic syndrome can interact with other illnesses by increasing risks during surgery, immobility, or severe infections, which is why hospitals often use extra precautions during admissions. If dialysis or a feeding tube is part of care, skin and line infections need quick attention, and some imaging dyes or antibiotics can be risky for kidney function, so clinicians tailor choices carefully. Early symptoms of Galloway-Mowat syndrome 1 can overlap with other childhood conditions, making it useful to keep a simple symptom diary and share it with specialists to spot patterns when one issue worsens another.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described infants who struggled to gain strength, had unusually small head size, and later developed kidney troubles that were difficult to explain. Families and communities once noticed patterns—two siblings with early feeding difficulties and delayed milestones, followed by swelling from kidney disease—but causes remained unclear. Doctors recorded these observations in different countries, yet the pieces did not fit together until the late 20th century.
First described in the medical literature as a link between early neurologic challenges and childhood kidney failure, this cluster of findings was later named Galloway-Mowat syndrome. Early reports focused on babies with very small head size, low muscle tone, and seizures, who then developed protein loss in the urine and edema. Initially understood only through symptoms, later studies showed that the kidney changes involved a specific filter problem, while the brain features reflected early developmental differences. As more cases were recognized, clinicians saw wide variation—some children developed kidney disease within the first year, while others had slower change, and a few had mainly neurologic features.
In recent decades, knowledge has built on a long tradition of observation. Advances in genetics clarified that several genes involved in how cells manage their internal structure and stress responses are important in Galloway-Mowat syndrome 1. This helped explain why the condition affects both the brain and the kidney’s delicate filtering units. It also showed that what doctors once viewed as a single, uniform disorder actually includes a spectrum, with Galloway-Mowat syndrome 1 referring to forms tied to specific gene changes.
Over time, descriptions became more precise. Researchers connected early symptoms of Galloway-Mowat syndrome 1—such as feeding difficulty, low muscle tone, and small head size—with later clinical features like heavy protein in the urine, swelling, and declining kidney function. Pathology studies of kidney tissue confirmed a characteristic pattern in the filters, while brain imaging and developmental assessments mapped the neurologic side. Not every early description was complete, yet together they built the foundation of today’s knowledge.
Today, the history of Galloway-Mowat syndrome 1 reflects a shift from scattered case notes to a clearer picture that guides care. Genetic testing can confirm the diagnosis, and supportive treatments are tailored to both neurologic needs and kidney health. Knowing the condition’s history helps explain why some families first meet neurology teams and others start with kidney specialists, and why both perspectives matter for a full understanding of the condition.